Acta Vet. Brno 2018, 87: 99-107

Effects of nonselective and selective cyclooxygenase inhibitors on the contractions of isolated bronchial smooth muscle in the horse

Alessandro Menozzi1, Cristina Pozzoli2, Enzo Poli2, Lucia Tagliaferri1, Giuseppe Placenza1, Simone Bertini1

1University of Parma, Department of Veterinary Science, Parma, Italy
2University of Parma, Department of Medicine and Surgery, Parma, Italy

Received February 1, 2018
Accepted May 15, 2018


1. Aboulafia J, Mendes GB, Miyamoto ME, Paiva AC, Paiva TB 1976: Effect of indomethacin and prostaglandin on the smooth muscle contracting activity of angiotensin and other agonists. Br J Pharmacol 58: 223-228 <>
2. Atukorala I, Hunter DJ 2013: Valdecoxib: the rise and fall of a COX-2 inhibitor. Expert Opin Pharmacother 14: 1077-1086 <>
3. Bianco S, Robuschi M, Damonte C, Simone P, Vaghi A, Pasargiklian M 1985: Bronchial response to nonsteroidal anti-inflammatory drugs in asthmatic patients. Prog Biochem Pharmacol 20: 132-142
4. Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, Day R, Ferraz MB, Hawkey CJ, Hochberg MC, Kvien TK, Schnitzer TJ, Group VS 2000: Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 343: 1520-1528 <>
5. Brideau C, Van Staden C, Chan CC 2001: In vitro effects of cyclooxygenase inhibitors in whole blood of horses, dogs, and cats. Am J Vet Res 62: 1755-1760 <>
6. Brink C, Grimaud C, Guillot C, Orehek J 1980: The interaction between indomethacin and contractile agents on human isolated airway muscle. Br J Pharmacol 69: 383-388 <>
7. Christie PE, Tagari P, Ford-Hutchinson AW, Charlesson S, Chee P, Arm JP, Lee TH 1991: Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Am Rev Respir Dis 143: 1025-1029 <>
8. Dabareiner RM, White NA 1995: Large colon impaction in horses: 147 cases (1985-1991). J Am Vet Med Assoc 206: 679-685
9. Douglas JS, Brink C 1987: Airway smooth muscle and disease workshop: histamine and prostanoids. Am Rev Respir Dis 136: S21-S24 <>
10. Futaki N, Takahashi S, Yokoyama M, Arai I, Higuchi S, Otomo S 1994: NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins 47: 55-59 <>
11. Gardiner PJ 1975: The effects of some natural prostaglandins on isolated human circular bronchial muscle. Prostaglandins 10: 607-616 <>
12. Goverdhan P, Sravanthi A, Mamatha T 2012: Neuroprotective effects of meloxicam and selegiline in scopolamine-induced cognitive impairment and oxidative stress. Int J Alzheimers Dis 2012: 974013
13. Gray PR, Derksen FJ, Broadstone RV, Robinson NE, Peters-Golden M 1992: Decreased airway mucosal prostaglandin E2 production during airway obstruction in an animal model of asthma. Am Rev Respir Dis 146: 586-591 <>
14. Grosenbaugh DA, Muir WW 1998: Cardiorespiratory effects of sevoflurane, isoflurane, and halothane anesthesia in horses. Am J Vet Res 59: 101-106
15. Hamberg M, Hedqvist P, Strandberg K, Svensson J, Samuelsson B 1975: Prostaglandin endoperoxides IV. Effects on smooth muscle. Life Sci 16: 451-462 <>
16. Hanley SP 1986: Prostaglandins and the lung. Lung 164: 65-77 <>
17. Harrington LS, Lucas R, McMaster SK, Moreno L, Scadding G, Warner TD, Mitchell JA 2008: COX-1, and not COX-2 activity, regulates airway function: relevance to aspirin-sensitive asthma. FASEB J 22: 4005-4010 <>
18. Haye-Legrand I, Cerrina J, Raffestin B, Labat C, Boullet C, Bayol A, Benveniste J, Brink C 1986: Histamine contraction of isolated human airway muscle preparations: role of prostaglandins. J Pharmacol Exp Ther 239: 536-541
19. Horton EW, Main IH 1965: A Comparison of the actions of prostaglandins F2-alpha and E1 on smooth muscle. Br J Pharmacol Chemother 24: 470-476 <>
20. Kargman S, Charleson S, Cartwright M, Frank J, Riendeau D, Mancini J, Evans J, O’Neill G 1996: Characterization of prostaglandin G/H synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts. Gastroenterology 111: 445-454 <>
21. Looney Y, O’Shea A, O’Dwyer R 2005: Severe bronchospasm after parenteral parecoxib: cyclooxygenase-2 inhibitors: not the answer yet. Anesthesiology 102: 473-475 <>
22. MacAllister CG, Morgan SJ, Borne AT, Pollet RA 1993: Comparison of adverse effects of phenylbutazone, flunixin meglumine, and ketoprofen in horses. J Am Vet Med Assoc 202: 71-77
23. MacKay RJ, French TW, Nguyen HT, Mayhew IG 1983: Effects of large doses of phenylbutazone administration to horses. Am J Vet Res 44: 774-780
24. Martin-Garcia C, Hinojosa M, Berges P, Camacho E, Garcia-Rodriguez R, Alfaya T 2003: Celecoxib, a highly selective COX-2 inhibitor, is safe in aspirin-induced asthma patients. J Investig Allergol Clin Immunol 13: 20-25
25. Martin-Garcia C, Hinojosa M, Berges P, Camacho E, Garcia-Rodriguez R, Alfaya T, Iscar A 2002: Safety of a cyclooxygenase-2 inhibitor in patients with aspirin-sensitive asthma. Chest 121: 1812-1817 <>
26. McGrogan I, Daniel EE 1996: Release and actions of inhibitory prostaglandins from canine tracheal epithelium. Can J Physiol Pharmacol 74: 1055-1060 <>
27. Menozzi A, Pozzoli C, Poli E, Delvescovo B, Serventi P, Bertini S 2014: Pharmacological characterization of muscarinic receptors in the contractions of isolated bronchi in the horse. J Vet Pharmacol Ther 37: 325-331 <>
28. Northover BJ 1971: Mechanism of the inhibitory action of indomethacin on smooth muscle. Br J Pharmacol 41: 540-551 <>
29. Orehek J, Douglas JS, Bouhuys A 1975: Contractile responses of the guinea-pig trachea in vitro: modification by prostaglandin synthesis-inhibiting drugs. J Pharmacol Exp Ther 194: 554-564
30. Orehek J, Douglas JS, Lewis AJ, Bouhuys A 1973: Prostaglandin regulation of airway smooth muscle tone. Nat New Biol 245: 84-85 <>
31. Parker AR, Ayars AG, Altman MC, Henderson WR, Jr. 2016: Lipid mediators in aspirin-exacerbated respiratory disease. Immunol Allergy Clin North Am 36: 749-763 <>
32. Parmar HS, Assaiya A, Agrawal R, Tiwari S, Mufti I, Jain N, Manivannan E, Banerjee T, Kumar A 2017: Inhibition of Aβ(1-42)oligomerization, fibrillization and acetylcholinesterase activity by some anti-inflammatory drugs: an in vitro study. Antiinflamm Antiallergy Agents Med Chem 15: 191-203 <>
33. Roberts MC 1982: Adverse effects of indomethacin in the horse. J Vet Pharmacol Ther 5: 83-86 <>
34. Sawdy R, Knock GA, Bennett PR, Poston L, Aaronson PI 1998: Effect of nimesulide and indomethacin on contractility and the Ca2+ channel current in myometrial smooth muscle from pregnant women. Br J Pharmacol 125: 1212-1217 <>
35. Shore SA, Powell WS, Martin JG 1985: Endogenous prostaglandins modulate histamine-induced contraction in canine tracheal smooth muscle. J Appl Physiol 58: 859-868 <>
36. Smith AP 1975: Effect of indomethacin in asthma: evidence against a role for prostaglandins in its pathogenesis. Br J Clin Pharmacol 2: 307-309 <>
37. Smith AP, Cuthbert MF 1976: The response of normal and asthmatic subjects to prostaglandins E2 and F2alpha by different routes, and their significance in asthma. Adv Prostaglandin Thromboxane Res 1: 449-459
38. Steinhoff MS, von Mentzer B, Geppetti P, Pothoulakis C, Bunnett NW 2014: Tachykinins and their receptors: contributions to physiological control and the mechanisms of disease. Physiol Rev 94: 265-301 <>
39. Xie WL, Chipman JG, Robertson DL, Erikson RL, Simmons DL 1991: Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA 88: 2692-2696 <>
40. Zhao WW, Robinson NE, Yu MF 1994: PGE2 inhibits acetylcholine release from cholinergic nerves in canine but not equine airways. Prostaglandins Leukot Essent Fatty Acids 51: 347-355
41. Zimmermann KC, Sarbia M, Schror K, Weber AA 1998: Constitutive cyclooxygenase-2 expression in healthy human and rabbit gastric mucosa. Mol Pharmacol 54: 536-540 <>
front cover
  • ISSN 0001-7213 (printed)
  • ISSN 1801-7576 (electronic)

Current issue

Indexed in DOAJ